Skip to content

Biohaven BHVN Prepaid & Other Current

Prepaid & Other Current at other companies

Eli Lilly logo
Eli LillyLLY
$13.63B-7.0%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$10.72M+47.7%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$7.75M+41.4%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$44.76M+5.6%
uniQure logo
uniQureQURE
$16.59M+23.6%
Roivant Sciences logo
Roivant SciencesROIV
$105.32M-6.9%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%
Enterprise value$2.26B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's prepaid & other current?
Biohaven (BHVN) reported prepaid & other current of $34.67M in Q1 2026.
How has Biohaven's prepaid & other current changed year-over-year?
Biohaven's prepaid & other current decreased by 38.5% year-over-year, from $56.39M to $34.67M.
What is the long-term trend for Biohaven's prepaid & other current?
Over 4 years (2021 to 2025), Biohaven's prepaid & other current has grown at a 100.4% compound annual growth rate (CAGR), from $13.62M to $219.88M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.